
About Emery Pharma
Emery Pharma is a company based in Alameda (United States) founded in 2011. Emery Pharma offers products and services including Analytical Services, Bioanalytical Services, Impurity Analysis, Biologics Characterization, and Cell and Microbiology Services. Emery Pharma operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Alameda, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website emerypharma.com
- Social LinkedIn Facebook YouTube
- Latest Funding Round$40K (USD), Grant
Sep 2017
- Investors
Products & Services of Emery Pharma
Emery Pharma offers a comprehensive portfolio of products and services, including Analytical Services, Bioanalytical Services, Impurity Analysis, Biologics Characterization, and Cell and Microbiology Services.
Provides analysis for drug development and quality control processes.
Offers testing for pharmacokinetics in drug research applications.
Conducts impurity detection in pharmaceutical products.
Performs characterization of biologics for development stages.
Delivers microbial testing for drug and botanical development.
Apps and channels of Emery Pharma
its YouTube channel Emery Pharma has 49K subscribers and 30 videos.
Videos from Emery Pharma
The most watched videos on Emery Pharma's YouTube channel, Emery Pharma (49K subscribers). Click a video to play it here.
More on Emery Pharma.
Funding Insights of Emery Pharma
- Total Rounds 1
- Last Round Grant — $39,998
- First Round $39,998
(Sep 2017)
- Investors Count 1
All 1 funding rounds of Emery Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | $39,998 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Emery Pharma
Emery Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Oceanic and Atmospheric Administration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | noaa.gov | - |
Investor details for Emery Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Emery Pharma
2 dated milestones of Emery Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Emery Pharma is founded.
- Funding First funding round of $40K.
Competitors of Emery Pharma
Emery Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| nuvisan.com | 1979 | Neu Ulm, Germany | – | 1,011 | Clinical trial supply and bioanalytical services are provided globally. | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services | |
| solvias.com | 1999 | Kaiseraugst, Switzerland | – | – | Integrated R&D services are provided for pharmaceuticals and allied sectors. |
Detailed competitors of Emery Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Emery Pharma
The website of Emery Pharma (emerypharma.com) receives about 19.2K visits a month.
- Monthly visits19.2K
▲ 32.6% vs previous month
Websites whose visitors overlap most with Emery Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| atomwise.com | 100% | 3.8K | #4,893,237 | View details | |
| xcellbio.com | 98% | 4.4K | #4,847,582 | View details | |
| situbiosciences.com | 89% | 2.5K | #6,743,764 | View details | |
| tempobioscience.com | 87% | 6.1K | #3,342,449 | View details | |
gsconlinepress.com | gsconlinepress.com | 76% | – | #478,779 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Emery Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Emery Pharma
Complete news archive for Emery Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Emery Pharma
10 companies that operate in the same segment as Emery Pharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emery Pharma
Emery Pharma was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Emery Pharma is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Emery Pharma is a full service contract research lab that specializes in offering microbiology cell-biology testing, medicinal chemistry, analytical chemistry and bio-analytical services. Their chemistry services include custom synthesis, medicinal chemistry support, NMR and LC-MS services. Their cell and microbiology testing services include MICMBC testing, antimicrobial efficacy and antibiotic resistance testing, biofilm testing, cytotoxicity testing and testing as per US Pharmacopoeia methods. In April 2017, the company entered into a collaboration with Quellthera, a subsidiary of Liveleaf for the development of phytobiologics against infectious diseases. Apart from serving clients in the US, they are also working with companies located in Russia, Ukraine, and Canada, and Brazil.
Emery Pharma's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Emery Pharma offers Analytical Services, Bioanalytical Services, Impurity Analysis, Biologics Characterization, and Cell and Microbiology Services.
Emery Pharma has 1 investor. Key investors include National Oceanic and Atmospheric Administration.
